Genetic variations in DNA-repair genes (XRCC1, 3, and 7) and the susceptibility to hepatocellular carcinoma in a cohort of Egyptians.

Autor: Aboul Enein AA; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., Khaled IAA; Department of Clinical and Chemical Pathology, Theoder Bilharz Research Institute, Cairo, Egypt., Khorshied MM; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., Abdel-Aziz AO; Department of Tropical Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt., Zahran N; Department of Clinical and Chemical Pathology, Theoder Bilharz Research Institute, Cairo, Egypt., El Saeed AM; Department of Clinical and Chemical Pathology, Theoder Bilharz Research Institute, Cairo, Egypt., Shousha HI; Department of Tropical Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt., Abdel Rahman HA; Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Jazyk: angličtina
Zdroj: Journal of medical virology [J Med Virol] 2020 Dec; Vol. 92 (12), pp. 3609-3616. Date of Electronic Publication: 2020 Jun 29.
DOI: 10.1002/jmv.25873
Abstrakt: Chronic hepatitis C (CHC) is a worldwide etiology of chronic hepatic insult particularly in Egypt. DNA-repair systems are responsible for maintaining genomic integrity by countering threats posed by DNA lesions. Deficiency in the repair capacity due to genetic alterations in DNA-repair genes can lead to genomic instability and increased risk of cancer development. The present work aimed at studying the possible association between XRCC1-G28152A (rs25487), XRCC3-C18067T (rs861539), and XRCC7-G6721T (rs7003908) single nucleotide polymorphisms (SNPs) and the susceptibility to hepatocellular carcinoma (HCC) in Egyptian population. The study was conducted on 100 newly diagnosed HCC patients and 100 age- and sex-matched healthy controls. Laboratory workup revealed that all HCC patients have chronic hepatitis C viral infection. Genotyping of the studied SNPs was performed by real-time PCR. The heteromutant genotype of XRCC1 (GA) conferred an almost two-fold increased risk of HCC (OR ,  2.35; 95% CI, 1.33-4.04). Regarding XRCC7, the heteromutant (TG) genotype conferred a two-fold increased risk of HCC (OR ,  2.17; 95% CI, 1.23-3.82). Coinheritance of the polymorphic genotypes of XRCC1 and 7 was significantly higher in HCC cases than controls and was associated with an 11-fold increased risk of HCC (OR , 11.66; 95% CI,  2.77-49.13). The frequency of XRCC3 polymorphic genotypes in HCC patients was close to that of the controls.
(© 2020 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: